AAPL345.41+1.42 (+0.41%) ▲|ABBV282.81-1.91 (-0.67%) ▼|ABT100.83+0.32 (+0.32%) ▲|ACN243.65+3.39 (+1.41%) ▲|ADBE261.00+5.94 (+2.33%) ▲|AMAT385.01-23.93 (-5.85%) ▼|AMD520.57-32.15 (-5.82%) ▼|AMGN447.10+8.76 (+2.00%) ▲|AMT181.05+3.41 (+1.92%) ▲|AMZN253.55-8.83 (-3.36%) ▼|AVGO328.88-8.92 (-2.64%) ▼|AXP325.91+2.30 (+0.71%) ▲|BA190.70-1.58 (-0.82%) ▼|BAC51.04+0.26 (+0.51%) ▲|BKNG164.56+6.18 (+3.90%) ▲|BLK1,152.99+3.39 (+0.29%) ▲|BMY62.13+1.01 (+1.65%) ▲|BNY144.81-1.05 (-0.72%) ▼|BRK-B545.07+6.08 (+1.13%) ▲|C123.17-0.68 (-0.55%) ▼|CAT710.58-29.63 (-4.00%) ▼|CL96.06+2.66 (+2.85%) ▲|CMCSA23.08+1.00 (+4.51%) ▲|COF208.00+1.34 (+0.65%) ▲|COP144.42-1.26 (-0.86%) ▼|COST1,005.53+7.22 (+0.72%) ▲|CRM245.89+4.11 (+1.70%) ▲|CSCO104.85-2.41 (-2.25%) ▼|CVS93.47+0.69 (+0.74%) ▲|CVX225.32-1.47 (-0.65%) ▼|DE632.04-4.50 (-0.71%) ▼|DHR233.42-0.45 (-0.19%) ▼|DIS112.53+0.70 (+0.63%) ▲|DUK122.53+1.86 (+1.54%) ▲|EMR157.73-5.38 (-3.30%) ▼|FDX302.19+3.96 (+1.33%) ▲|GD346.65+1.94 (+0.56%) ▲|GE290.96-4.92 (-1.66%) ▼|GEV849.17-76.75 (-8.29%) ▼|GILD156.14+2.57 (+1.67%) ▲|GM77.98+1.87 (+2.46%) ▲|GOOG323.80-7.15 (-2.16%) ▼|GOOGL327.81-6.95 (-2.08%) ▼|GS899.02-5.71 (-0.63%) ▼|HD322.34+8.20 (+2.61%) ▲|HON213.10-1.64 (-0.76%) ▼|IBM243.58-7.88 (-3.13%) ▼|INTC88.10-4.86 (-5.23%) ▼|INTU347.07+11.46 (+3.41%) ▲|ISRG436.70+8.58 (+2.00%) ▲|JNJ263.16+5.38 (+2.09%) ▲|JPM335.97+0.78 (+0.23%) ▲|KO94.12+1.44 (+1.55%) ▲|LIN504.02+3.45 (+0.69%) ▲|LLY1,305.45+34.70 (+2.73%) ▲|LMT587.36+35.85 (+6.50%) ▲|LOW201.93+5.37 (+2.73%) ▲|LRCX238.04-22.77 (-8.73%) ▼|MA627.22+4.60 (+0.74%) ▲|MCD249.03+2.78 (+1.13%) ▲|MDLZ63.83+1.09 (+1.74%) ▲|MDT94.57+1.54 (+1.66%) ▲|META655.19-42.33 (-6.07%) ▼|MMM175.45+0.71 (+0.40%) ▲|MO74.82+0.99 (+1.34%) ▲|MRK153.13+3.25 (+2.17%) ▲|MS185.19-1.82 (-0.97%) ▼|MSFT524.76-8.20 (-1.54%) ▼|MU897.15-16.52 (-1.81%) ▼|NEE80.42+2.14 (+2.73%) ▲|NFLX66.40+1.36 (+2.09%) ▲|NKE37.75+0.22 (+0.57%) ▲|NOW155.48+2.36 (+1.54%) ▲|NVDA215.93-6.04 (-2.72%) ▼|ORCL127.11-2.03 (-1.57%) ▼|PEP136.89+2.19 (+1.63%) ▲|PFE30.26+0.41 (+1.37%) ▲|PG165.05+8.21 (+5.23%) ▲|PLTR201.64-0.08 (-0.04%) ▼|PM199.56+2.10 (+1.06%) ▲|QCOM177.27-0.70 (-0.39%) ▼|RTX192.52+0.92 (+0.48%) ▲|SBUX100.73+1.65 (+1.67%) ▲|SCHW92.04+0.40 (+0.44%) ▲|SO92.03+1.64 (+1.81%) ▲|SPG209.18+3.63 (+1.76%) ▲|T22.60+0.69 (+3.15%) ▲|TMO683.90-10.12 (-1.46%) ▼|TMUS158.02+4.27 (+2.78%) ▲|TSLA387.00+0.53 (+0.14%) ▲|TXN283.52-1.13 (-0.40%) ▼|UBER68.50+0.88 (+1.29%) ▲|UNH422.09+5.09 (+1.22%) ▲|UNP294.15+6.28 (+2.18%) ▲|UPS100.98+1.41 (+1.42%) ▲|USB59.68+0.63 (+1.06%) ▲|V410.99+3.14 (+0.77%) ▲|VZ44.82+1.26 (+2.88%) ▲|WFC83.08+0.66 (+0.80%) ▲|WMT118.77+0.97 (+0.82%) ▲|XOM176.60-1.49 (-0.84%) ▼|AAPL345.41+1.42 (+0.41%) ▲|ABBV282.81-1.91 (-0.67%) ▼|ABT100.83+0.32 (+0.32%) ▲|ACN243.65+3.39 (+1.41%) ▲|ADBE261.00+5.94 (+2.33%) ▲|AMAT385.01-23.93 (-5.85%) ▼|AMD520.57-32.15 (-5.82%) ▼|AMGN447.10+8.76 (+2.00%) ▲|AMT181.05+3.41 (+1.92%) ▲|AMZN253.55-8.83 (-3.36%) ▼|AVGO328.88-8.92 (-2.64%) ▼|AXP325.91+2.30 (+0.71%) ▲|BA190.70-1.58 (-0.82%) ▼|BAC51.04+0.26 (+0.51%) ▲|BKNG164.56+6.18 (+3.90%) ▲|BLK1,152.99+3.39 (+0.29%) ▲|BMY62.13+1.01 (+1.65%) ▲|BNY144.81-1.05 (-0.72%) ▼|BRK-B545.07+6.08 (+1.13%) ▲|C123.17-0.68 (-0.55%) ▼|CAT710.58-29.63 (-4.00%) ▼|CL96.06+2.66 (+2.85%) ▲|CMCSA23.08+1.00 (+4.51%) ▲|COF208.00+1.34 (+0.65%) ▲|COP144.42-1.26 (-0.86%) ▼|COST1,005.53+7.22 (+0.72%) ▲|CRM245.89+4.11 (+1.70%) ▲|CSCO104.85-2.41 (-2.25%) ▼|CVS93.47+0.69 (+0.74%) ▲|CVX225.32-1.47 (-0.65%) ▼|DE632.04-4.50 (-0.71%) ▼|DHR233.42-0.45 (-0.19%) ▼|DIS112.53+0.70 (+0.63%) ▲|DUK122.53+1.86 (+1.54%) ▲|EMR157.73-5.38 (-3.30%) ▼|FDX302.19+3.96 (+1.33%) ▲|GD346.65+1.94 (+0.56%) ▲|GE290.96-4.92 (-1.66%) ▼|GEV849.17-76.75 (-8.29%) ▼|GILD156.14+2.57 (+1.67%) ▲|GM77.98+1.87 (+2.46%) ▲|GOOG323.80-7.15 (-2.16%) ▼|GOOGL327.81-6.95 (-2.08%) ▼|GS899.02-5.71 (-0.63%) ▼|HD322.34+8.20 (+2.61%) ▲|HON213.10-1.64 (-0.76%) ▼|IBM243.58-7.88 (-3.13%) ▼|INTC88.10-4.86 (-5.23%) ▼|INTU347.07+11.46 (+3.41%) ▲|ISRG436.70+8.58 (+2.00%) ▲|JNJ263.16+5.38 (+2.09%) ▲|JPM335.97+0.78 (+0.23%) ▲|KO94.12+1.44 (+1.55%) ▲|LIN504.02+3.45 (+0.69%) ▲|LLY1,305.45+34.70 (+2.73%) ▲|LMT587.36+35.85 (+6.50%) ▲|LOW201.93+5.37 (+2.73%) ▲|LRCX238.04-22.77 (-8.73%) ▼|MA627.22+4.60 (+0.74%) ▲|MCD249.03+2.78 (+1.13%) ▲|MDLZ63.83+1.09 (+1.74%) ▲|MDT94.57+1.54 (+1.66%) ▲|META655.19-42.33 (-6.07%) ▼|MMM175.45+0.71 (+0.40%) ▲|MO74.82+0.99 (+1.34%) ▲|MRK153.13+3.25 (+2.17%) ▲|MS185.19-1.82 (-0.97%) ▼|MSFT524.76-8.20 (-1.54%) ▼|MU897.15-16.52 (-1.81%) ▼|NEE80.42+2.14 (+2.73%) ▲|NFLX66.40+1.36 (+2.09%) ▲|NKE37.75+0.22 (+0.57%) ▲|NOW155.48+2.36 (+1.54%) ▲|NVDA215.93-6.04 (-2.72%) ▼|ORCL127.11-2.03 (-1.57%) ▼|PEP136.89+2.19 (+1.63%) ▲|PFE30.26+0.41 (+1.37%) ▲|PG165.05+8.21 (+5.23%) ▲|PLTR201.64-0.08 (-0.04%) ▼|PM199.56+2.10 (+1.06%) ▲|QCOM177.27-0.70 (-0.39%) ▼|RTX192.52+0.92 (+0.48%) ▲|SBUX100.73+1.65 (+1.67%) ▲|SCHW92.04+0.40 (+0.44%) ▲|SO92.03+1.64 (+1.81%) ▲|SPG209.18+3.63 (+1.76%) ▲|T22.60+0.69 (+3.15%) ▲|TMO683.90-10.12 (-1.46%) ▼|TMUS158.02+4.27 (+2.78%) ▲|TSLA387.00+0.53 (+0.14%) ▲|TXN283.52-1.13 (-0.40%) ▼|UBER68.50+0.88 (+1.29%) ▲|UNH422.09+5.09 (+1.22%) ▲|UNP294.15+6.28 (+2.18%) ▲|UPS100.98+1.41 (+1.42%) ▲|USB59.68+0.63 (+1.06%) ▲|V410.99+3.14 (+0.77%) ▲|VZ44.82+1.26 (+2.88%) ▲|WFC83.08+0.66 (+0.80%) ▲|WMT118.77+0.97 (+0.82%) ▲|XOM176.60-1.49 (-0.84%) ▼|
16.1 C
New York
Thursday, October 22, 2026

Tag: disease

iReprogram Partners with University of Michigan on Multimillion-Dollar Initiative to Reprogram Cells for Diabetes

Backed by the Look to Michigan Strategic Initiative Fund, the collaboration aims to accelerate patient-derived cell therapies to pioneer comprehensive diabetes treatments.ANN ARBOR, Mich.,...

American Liver Foundation Hosts MASH: Empower and Educate Summit

Patients with MASLD/MASH from Across the U.S. Gathered in Chicago for Educational Workshops and EventsCHICAGO, Oct. 21, 2026 /PRNewswire/ -- American Liver Foundation (ALF) hosted...

Illumina BioInsight Platform expands with new software to accelerate the path from sequencing to discovery

DRAGEN Ultra, BioInsight Platform Workflow Orchestrator, and BioInsight Platform Learning Cohorts are now available in early access, incorporating new AI-driven approaches to analysis, automation,...

Geneos Therapeutics Initiates IMPACT31 Phase 2 Randomized Clinical Trial Evaluating Neoantigen-Targeted Personalized DNA Immunotherapy for Cancer

The study evaluates patients with liver cancer at high risk of recurrence following surgical resectionJulie Rosenberg, MD, appointed to leadership team as Chief Medical...

Lumen Bio Reports Positive Phase 2 Results from the RePreve Clinical Trial (LMN-201 for C. difficile Infection)

- Global cure observed in 83.3% of LMN-201 recipients versus 36.4% randomized to placebo- LMN-201 treatment plus standard-of-care antibiotics demonstrated a six-fold reduction in...

Arctic Therapeutics closes oversubscribed US$21.5 million financing

The financing round, led by investment firm Pekron, Investcorp-backed Sanos Group, Icelandic investment company Kaldbakur and Landvættir, an Icelandic venture capital fund managed by...

Arctic Therapeutics closes oversubscribed US$21.5 million financing

The financing round, led by investment firm Pekron, Investcorp-backed Sanos Group, Icelandic investment company Kaldbakur and Landvættir, an Icelandic venture capital fund managed by...

Hengrui Pharma Previews ESMO Congress 2026: 64 Research Findings Highlight Continued Progress Across Innovative Pipelines to Advance Clinical Value

64 research findings have been accepted, including three Proffered Paper presentations and three Rapid Oral presentations, spanning more than ten areas of oncology and...

DaVita Responds to HHS Kidney Care National Plan, Reaffirms Commitment to Innovation, Access and Patient Choice

DENVER, Oct. 20, 2026 /PRNewswire/ -- DaVita today issued the following statement in response to the U.S. Department of Health and Human Services' Kidney Care...

Telix Reports Third Quarter 2026 Financial Performance

MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a financial update on its commercial...

AMGEN TO PRESENT AT THE EUROPEAN SOCIETY OF MEDICAL ONCOLOGY CONGRESS 2026

THOUSAND OAKS, Calif., Oct. 20, 2026 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with the European Society of...

INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science

PLYMOUTH MEETING, Pa., Oct. 20, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to...

Early LGS-CORE Registry Data Show Only 4% of Reported Treatments Stopped All Seizures in Lennox-Gastaut Syndrome

SAN DIEGO, Oct. 20, 2026 /PRNewswire/ -- The Lennox-Gastaut Syndrome (LGS) Foundation will present the first data from its LGS Collaborative Outcomes Registry (LGS-CORE)...

Sun Pharma Announces UNLOXCYT® (cosibelimab-ipdl) Has Received a Category 2A Preferred Designation in the Updated NCCN Guidelines for Locally Advanced Cutaneous Squamous Cell Carcinoma...

MUMBAI, India and PRINCETON, N.J., Oct. 20, 2026 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDisease